<style>
.trajectory-box strong {
  color: #1a1a1a !important;
}
.trajectory-box h3 {
  color: #1a1a1a !important;
}
</style>

# lm-planner/gemini-2.5-flash/MF_LAL__Drug_Compound_Generation_Using_Multi_Fidelity_Latent_Space_Active_Learning

<div style="background: linear-gradient(135deg, #e3f2fd 0%, #bbdefb 100%); border-left: 5px solid #2196f3; padding: 20px; margin: 20px 0; border-radius: 8px; box-shadow: 0 2px 8px rgba(0,0,0,0.1); color: #1a1a1a;" class="trajectory-box">
<h2 style="color: #1976d2; margin-top: 0; margin-bottom: 15px; font-size: 1.3em;">ðŸ§  Reasoning Trace</h2>

The paper "MF-LAL: Drug Compound Generation Using Multi-Fidelity Latent Space Active Learning" proposes a novel framework integrating generative modeling and multi-fidelity surrogate modeling for drug discovery. The core components include a hierarchical structure of latent spaces, one for each fidelity level, connected by networks that pass information between levels. It also employs a Bayesian active learning strategy with a specific method for switching between querying different fidelity oracles based on model uncertainty, and a novel likelihood-based term in the generation objective.

The paper includes several ablation studies in Table 2:
1.  Removing each fidelity level individually (-FID. 1, -FID. 2, -FID. 3, -FID. 4) to assess the contribution of each oracle.
2.  Removing the novel likelihood term from the generation objective (W/O LIKELIHOOD TERM) to show its importance.
3.  Replacing the fully-connected encoder/decoder with Transformer or GCN architectures (TRANSFORMER ENC/DEC, GCN ENC/DEC) to evaluate the impact of the network architecture.

While these ablations cover important aspects like the contribution of individual fidelities and the novel likelihood term, they do not fully explore the impact of other core architectural and algorithmic choices. Specifically, two key aspects that are central to the MF-LAL framework and are not ablated are:

1.  **The Hierarchical Multi-Latent Space Architecture:** The paper highlights the use of separate, hierarchically connected latent spaces for each fidelity as a key difference from previous approaches that use a single shared latent space (like the VAE + 4x SF-GP and VAE + MF-GP baselines). An ablation study removing this hierarchical structure and using a single shared latent space within the MF-LAL framework would directly assess the contribution of this specific architectural design choice. This is distinct from the baselines, as the single-latent-space version would still use the joint training objective and the MF-LAL active learning/generation procedure.
2.  **The Active Learning Fidelity Switching Strategy:** The paper describes a specific active learning strategy where the model starts by querying the lowest fidelity and only moves to higher fidelities when the model's uncertainty at the current level falls below a threshold. This adaptive, uncertainty-driven switching is a core part of the active learning algorithm. An ablation study replacing this strategy with a simpler, non-adaptive approach (e.g., a fixed schedule for querying fidelities) would demonstrate the value of the proposed adaptive switching mechanism for sample efficiency and performance.

These two missing ablations are important because they directly probe the contribution of the unique architectural design (multi-latent spaces vs. single) and the specific active learning strategy, which are presented as key innovations of MF-LAL. Ablating these would provide stronger evidence for why MF-LAL outperforms baselines and which components are most critical.

The metrics used in the paper for evaluating generated compounds are the mean and top 3 ABFE scores (KCAL/MOL). These should be used for the proposed ablations to allow for direct comparison with the main results and existing ablations.

Based on their fundamental nature to the MF-LAL design, the ablation of the latent space architecture is arguably the most important missing study, followed by the active learning strategy.
</div>

<div style="background: linear-gradient(135deg, #e8f5e8 0%, #c8e6c9 100%); border-left: 5px solid #4caf50; padding: 20px; margin: 20px 0; border-radius: 8px; box-shadow: 0 2px 8px rgba(0,0,0,0.1); color: #1a1a1a;" class="trajectory-box">
<h2 style="color: #2e7d32; margin-top: 0; margin-bottom: 15px; font-size: 1.3em;">ðŸ“‹ Ablation Plan</h2>

### Ablation: Single Latent Space
- **Ablated Part**: Hierarchical multi-latent space architecture with separate latent spaces per fidelity and inter-fidelity connections (h networks)
- **Action**: REPLACE
- **Replacement**: 
  - Single shared latent space for all fidelities
- **Metrics**: MEAN Â± S.D. ABFE (KCAL/MOL), 1ST ABFE (KCAL/MOL), 2ND ABFE (KCAL/MOL), 3RD ABFE (KCAL/MOL)

### Ablation: Fixed Fidelity Switching
- **Ablated Part**: Uncertainty-based adaptive fidelity switching strategy during active learning
- **Action**: REPLACE
- **Replacement**: 
  - Fixed schedule for querying fidelities (e.g., spend X queries at f1, then Y at f2, etc.)
- **Metrics**: MEAN Â± S.D. ABFE (KCAL/MOL), 1ST ABFE (KCAL/MOL), 2ND ABFE (KCAL/MOL), 3RD ABFE (KCAL/MOL)

</div>